Skip to main content
. 2020 Jun 29;12(7):1731. doi: 10.3390/cancers12071731
2-HG 2-hydroxyglutarate
5-FU 5-fluorouracil
ACC acetyl CoA carboxylase
2-HG 2-hydroxyglutarate
ADP adenosine diphosphate
αKG α ketoglutarate
AKT protein kinase B
AML acute myeloid leukemia
AMPK 5’ AMP-activated protein kinase
Bax Bcl-2-associated X protein
BW body weight
CAF cancer-associated fibroblast
CD cluster of differentiation
CDK cyclin-dependent kinase
CIMP CpG island methylator phenotype
COX cyclooxygenase
CRC colorectal cancer
CSC cancer stem cell
CYP cytochrome P450
DCA dichloroacetate
dMMR DNA mismatch repair system
DNA deoxyribonucleic acid
E4BP eIF4E binding protein
ECM extracellular matrix
EGFR endothelial growth factor receptor
EMA European Medicines Agency
EMT epithelial–mesenchymal transition
ERK extracellular-signal regulated kinases
FAD flavin adenine dinucleotide
FDA Food and Drug Administration
FOLFIRI fluorouracil, leucovorin and irinotecan
FOLFIRINOX fluorouracil, leucovorin, irinotecan and oxaliplatin
FOLFOX fluorouracil, leucovorin and oxaliplatin
G6PD glucose-6-phosphate dehydrogenase
GLS glutaminase
GLUD glutamate dehydrogenase
GLUT glucose transporter
GOT glutamic-oxaloacetic transaminase
GTP glutamate pyruvate transaminase
GTP guanosine-5’-triphosphate
HIF hypoxia-inducible factor
HK hexokinase
HRE hypoxia response element
IBD inflammatory bowel disease
IC50 inhibitory concentration (50%)
IDH isocitrate dehydrogenase
IGF insulin-like growth factor
KGDH α-ketoglutarate dehydrogenase complex
LA α-lipoic acid
LC3B microtubule-associated protein
LDHA lactate dehydrogenase A
MAPK mitogen-activated protein kinase
MCT monocarboxylate transporter
MDR multidrug resistant protein
MGMT O6-methylguanine-DNA methyltransferase
MOM mitochondrial outer membrane
MPC mitochondrial pyruvate carrier
MSI microsatellite instable
MSS microsatellite stable
mtDNA mitochondrial DNA
MTD maximum tolerable dose
MTHFD2 methylenetetrahydrofolate dehydrogenase
mTOR mammalian target of rapamycin
MYC myelocytomatosis
NFκB nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells
Nrf nuclear factor erythroid-2-related factor
OXPHOS oxidative phosphorylation
PARP poly(ADP-ribose) polymerase
PDGF platelet-derived growth factor
PGC peroxisome proliferator-activated receptor gamma coactivator
PDC pyruvate dehydrogenase complex
PDCD4 programmed cell death protein
PDK pyruvate dehydrogenase kinase
PEG2 prostaglandin E2
PEG polyethylene glycol
PET positron emission tomography
PFK phosphofructokinase
PHD prolyl hydroxylase domain protein
PI3K phosphoinositide 3-kinases
PIP2 phosphatidylinositol-4,5-bisphosphate
PIP3 phosphatidyl-inositol-3,4,5-trisphosphate
PKM pyruvate kinase
PPP pentose phosphate pathway
ROS reactive oxygen species
RTK receptor tyrosine kinases
S6K1 p70S6 Kinase 1
S9 supernatant 9000 g,—
SCO synthesis of cytochrome c oxidase
SLC solute carrier
SREBP sterol responsive element binding protein
TAM tumor associated macrophages
TCA tricarboxylic acid cycle
Teff cell effector T cell
TGF transforming growth factor
TME tumor microenvironment
TIGAR TP53-inducible glycolysis and apoptosis regulator
Treg cell regulatory T cell
VEGF vascular endothelial growth factor